Validation of a new integrated prognostic score to predict non-relapse mortality in patients undergoing reduced-intensity conditioning allogeneic hematopoietic cell transplantation

Bone Marrow Transplant. 2015 Oct;50(10):1371-4. doi: 10.1038/bmt.2015.144. Epub 2015 Jun 22.

Authors

P Barba¹, R Martino², G Orti¹, A Esquirol², S Perez-Hoyos³, J Sierra², D Valcárcel¹

Affiliations

¹ Hematology Departments of Hospital Universitari Vall d'Hebron-Universitat Autònoma de Barcelona, Barcelona, Spain.
² Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
³ Unitat de Suport Metodològic, Vall Hebron Institut de Recerca, Barcelona, Spain.

PMID: 26098954
DOI: 10.1038/bmt.2015.144

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Aged
Female
Hematopoietic Stem Cell Transplantation / methods
Hematopoietic Stem Cell Transplantation / mortality*
Humans
Male
Middle Aged
Prognosis
Transplantation Conditioning / methods
Transplantation Conditioning / mortality*
Transplantation, Homologous / methods
Transplantation, Homologous / mortality*
Validation Studies as Topic*
Young Adult